Biolife Solutions
(BLFS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,045 | 29,725 | 27,896 | 19,266 | 21,431 |
| Marketable Securities | 12,120 | 15,579 | 16,288 | 21,794 | 24,858 |
| Receivables | 18,064 | 18,574 | 7,898 | 24,556 | 26,860 |
| Inventories | 32,496 | 43,414 | 27,164 | 43,354 | 39,177 |
| Other current assets | 0 | 0 | 36,691 | 0 | 0 |
| TOTAL | $88,200 | $111,700 | $120,604 | $116,824 | $120,311 |
| Non-Current Assets | |||||
| PPE Net | 17,256 | 21,042 | 5,689 | 20,998 | 25,565 |
| Investments And Advances | 3,683 | 5,891 | 5,617 | 6,225 | 6,908 |
| Intangibles | 244,066 | 244,976 | 224,300 | 246,805 | 253,918 |
| Other Non-Current Assets | 21,771 | 17,993 | 56,504 | 20,300 | 26,475 |
| TOTAL | $286,776 | $289,902 | $292,110 | $294,328 | $312,866 |
| Total Assets | $374,976 | $401,602 | $412,714 | $411,152 | $433,177 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 10,614 | 8,619 | 6,285 | 5,034 | 1,935 |
| Accounts payable and accrued liabilities | 4,213 | 4,984 | 2,270 | 11,980 | 10,686 |
| Accrued Expenses | 8,128 | 8,863 | 9,121 | 8,568 | 10,114 |
| Other current liabilities | 5,043 | 13,195 | 4,400 | 13,736 | 13,511 |
| TOTAL | $30,819 | $38,658 | $42,178 | $42,622 | $39,587 |
| Non-Current Liabilities | |||||
| Long Term Debt | 10,451 | 15,681 | 24,064 | 20,937 | 23,572 |
| Other Non-Current Liabilities | 11,075 | 12,579 | 8,695 | 14,040 | 16,297 |
| TOTAL | $22,715 | $29,539 | $32,873 | $36,513 | $41,462 |
| Total Liabilities | $53,534 | $68,197 | $75,051 | $79,135 | $81,049 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,138 | 46,031 | 45,300 | 44,031 | 43,490 |
| Common Shares | 46 | 46 | 45 | 44 | 43 |
| Retained earnings | -345,857 | -325,138 | -314,917 | -299,960 | -270,828 |
| Other shareholders' equity | -555 | -566 | -345 | -660 | -499 |
| TOTAL | $321,442 | $333,405 | $337,663 | $332,017 | $352,128 |
| Total Liabilities And Equity | $374,976 | $401,602 | $412,714 | $411,152 | $433,177 |